Tomomi Ishihara

858 total citations
13 papers, 726 citations indexed

About

Tomomi Ishihara is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Tomomi Ishihara has authored 13 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Physiology and 3 papers in Surgery. Recurrent topics in Tomomi Ishihara's work include Peroxisome Proliferator-Activated Receptors (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Adipose Tissue and Metabolism (4 papers). Tomomi Ishihara is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Adipose Tissue and Metabolism (4 papers). Tomomi Ishihara collaborates with scholars based in Japan, United States and Sweden. Tomomi Ishihara's co-authors include Kenji Arakawa, Akira Saito, Akira Oku, Masao Nawano, Kiichiro Ueta, Mamoru Matsumoto, Teruo Kawada, Kazuyuki Kitamura, Motonobu Anai and Hitoshi Endou and has published in prestigious journals such as Diabetes, Biochemical and Biophysical Research Communications and Infection and Immunity.

In The Last Decade

Tomomi Ishihara

12 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomomi Ishihara Japan 10 368 362 231 163 73 13 726
Shlomit Koren Israel 13 302 0.8× 310 0.9× 152 0.7× 103 0.6× 77 1.1× 39 713
Kiyohiko Negishi Japan 15 289 0.8× 223 0.6× 172 0.7× 99 0.6× 75 1.0× 31 686
Yu Togashi Japan 19 371 1.0× 355 1.0× 354 1.5× 109 0.7× 116 1.6× 44 820
Kentaro Toyoda Japan 15 464 1.3× 265 0.7× 415 1.8× 101 0.6× 84 1.2× 33 781
Ki-Up Lee South Korea 8 109 0.3× 426 1.2× 112 0.5× 232 1.4× 138 1.9× 9 792
Tracy Goh Canada 9 164 0.4× 287 0.8× 184 0.8× 220 1.3× 109 1.5× 12 632
A. van Tol Netherlands 17 371 1.0× 362 1.0× 266 1.2× 159 1.0× 137 1.9× 28 938
Tadasu Ikeda Japan 11 196 0.5× 211 0.6× 123 0.5× 95 0.6× 40 0.5× 31 472
Michael E. Pape United States 13 107 0.3× 348 1.0× 299 1.3× 137 0.8× 84 1.2× 24 708
Gina M. Butrico United States 12 252 0.7× 527 1.5× 271 1.2× 289 1.8× 242 3.3× 14 920

Countries citing papers authored by Tomomi Ishihara

Since Specialization
Citations

This map shows the geographic impact of Tomomi Ishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomomi Ishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomomi Ishihara more than expected).

Fields of papers citing papers by Tomomi Ishihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomomi Ishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomomi Ishihara. The network helps show where Tomomi Ishihara may publish in the future.

Co-authorship network of co-authors of Tomomi Ishihara

This figure shows the co-authorship network connecting the top 25 collaborators of Tomomi Ishihara. A scholar is included among the top collaborators of Tomomi Ishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomomi Ishihara. Tomomi Ishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Asaoka, Daisuke, Tomomi Ishihara, Sachiko Ezoe, et al.. (2024). Randomized, multicenter, active-controlled open-label study of NPC-25, zinc histidine hydrate, (non-inferiority to NOBELZIN™, zinc acetate dihydrate) for patients with hypozincemia. Journal of Trace Elements in Medicine and Biology. 87. 127558–127558.
2.
Ishihara, Tomomi, et al.. (2019). Twin-Arginine Translocation System Is Involved in Citrobacter rodentium Fitness in the Intestinal Tract. Infection and Immunity. 88(3). 5 indexed citations
3.
Tsuchida, Takuma, Sayaka Fukuda, Tomomi Ishihara, et al.. (2012). MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice. Lipids in Health and Disease. 11(1). 75–75. 35 indexed citations
4.
Fujita, Takuya, Shigetada Furukawa, Kentaro Morita, et al.. (2005). Glucosamine induces lipid accumulation and adipogenic change in C2C12 myoblasts. Biochemical and Biophysical Research Communications. 328(2). 369–374. 9 indexed citations
5.
Ueta, Kiichiro, Tomomi Ishihara, Yukio Matsumoto, et al.. (2005). Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats. Life Sciences. 76(23). 2655–2668. 72 indexed citations
6.
Arakawa, Kenji, et al.. (2004). An antidiabetic thiazolidinedione induces eccentric cardiac hypertrophy by cardiac volume overload in rats. Clinical and Experimental Pharmacology and Physiology. 31(1-2). 8–13. 45 indexed citations
7.
Arakawa, Kenji, Tomomi Ishihara, Akira Oku, et al.. (2001). Improved diabetic syndrome in C57BL/KsJ‐db/db mice by oral administration of the Na+‐glucose cotransporter inhibitor T‐1095. British Journal of Pharmacology. 132(2). 578–586. 128 indexed citations
8.
Oku, Akira, Kiichiro Ueta, Kenji Arakawa, et al.. (1999). T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.. Diabetes. 48(9). 1794–1800. 215 indexed citations
9.
Arakawa, Kenji, et al.. (1998). Actions of novel antidiabetic thiazolidinedione, T‐174, in animal models of non‐insulin‐dependent diabetes mellitus (NIDDM) and in cultured muscle cells. British Journal of Pharmacology. 125(3). 429–436. 33 indexed citations
10.
Matsuda, Kenichi, et al.. (1998). The interaction between vitamin A and thiazolidinedione on bovine adipocyte differentiation in primary culture.. Journal of Animal Science. 76(1). 61–61. 75 indexed citations
11.
Kawada, Teruo, et al.. (1998). THIAZOLIDINEDIONE INDUCES THE ADIPOSE DIFFERENTIATION OF FIBROBLAST‐LIKE CELLS RESIDENT WITHIN BOVINE SKELETAL MUSCLE. Cell Biology International. 22(6). 421–427. 27 indexed citations
12.
13.
Amemiya, Seiichiro, et al.. (1990). Altered synthesis of renin in patients with insulin-dependent diabetes: plasma prorenin as a marker predicting the evolution of nephropathy. Diabetes Research and Clinical Practice. 10(2). 115–122. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shlomit Koren Breakdown of academic impact, for papers by Kiyohiko Negishi Breakdown of academic impact, for papers by Yu Togashi Breakdown of academic impact, for papers by Kentaro Toyoda Breakdown of academic impact, for papers by Ki-Up Lee Breakdown of academic impact, for papers by Tracy Goh Breakdown of academic impact, for papers by A. van Tol Breakdown of academic impact, for papers by Tadasu Ikeda Breakdown of academic impact, for papers by Michael E. Pape Breakdown of academic impact, for papers by Gina M. Butrico
Rankless by CCL
2026